ReviewAnnals of hematology2025

Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: eligibility, best practices, and improving transplant outcomes.

Sarah A Wall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.